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Abstract The management of patients with isolated con-
genital complete atrioventricular block (CCAVB) has
changed during the last decades. The current policy is to pace
the majority of patients based on a variety of criteria, among
which is limited exercise capacity. Data regarding exercise
capacity in this population stems from previous publications
reporting small case series of unpaced patients. Therefore,
we have investigated the exercise capacity of a group of
contemporary children with CCAVB. Sixteen children
(mean age 11.5 ± 4; seven boys, nine girls) with CCAVB
were tested. In 13 patients, a median number of three pace-
makers were implanted, whereas in three patients no pace-
maker was given. All patients had an echocardiogram
and completed a cardiopulmonary cycle exercise test.
Exercise parameters were determined and compared
with reference values obtained from healthy Dutch peers.
The peak oxygen uptake/body mass was reduced to
34.4 ± 9.5 ml kg-1 min-1 (79 ± 24% of predicted) and
the ventilatory threshold was reduced to 52 ± 17% of peak
oxygen uptake (78 ± 21% of predicted), whereas the peak
work load/body mass was 2.8 ± 0.6 W/kg (91 ± 24% of
predicted), which was similar to controls. Importantly, 25%
of the paced patients showed upper rate restriction by the
pacemaker. In conclusion, children with CCAVB show a
reduced peak oxygen uptake and ventilatory threshold,
whereas they show normal peak work rates. This indicates
that they generate more energy during exercise from anaer-
obic energy sources. Paced children with CCAVB do not
perform better than unpaced children.
Keywords Exercise test  Exercise tolerance 
Congenital defects  Atrioventricular block
Introduction
Isolated congenital complete atrioventricular block (CCAVB)
is a rare cardiac disorder with an estimated incidence of
1/15,000–20,000 live births [27]. In most cases it occurs after
damage of a normally structured fetal heart by maternal
autoantibodies against ribonucleoproteins (anti-Ro/SSA, anti-
La/SSB) [24]. Along with the congenital antibody-associated
AV block, a variety of congenital forms of AV block occur
secondary to other congenital cardiac defects [25].
Management of patients with CCAVB has changed
during the last decennia. In the past, a minority of patients
received a pacemaker whereas the current policy is to pace
the majority of patients based on a variety of criteria,
among which is limited exercise capacity [10].
Exercise capacity provides relevant information about
the health status and the ability to perform age-appropriate
activities. Furthermore, it is a known predictor of mortality
A. C. Blank (&)  J. L. Strengers
Department of Pediatric Cardiology, Wilhelmina Children’s
Hospital, University Medical Center, P.O. Box 85090, 3508 AB
Utrecht, The Netherlands
e-mail: a.c.blank@umcutrecht.nl
S. Hakim  T. A. van Veen  M. A. Vos
Division of Heart and Lungs, Department of Medical
Physiology, University Medical Center, Yalelaan 50, 3584 CM
Utrecht, The Netherlands
R. B. Tanke
Department of Pediatric Cardiology, University Medical Center
St. Radboud, P.O. Box 9101, 6500 HB Nijmegen, The
Netherlands
T. Takken
Child Development and Exercise Center, Wilhelmina Children’s
Hospital, University Medical Center, P.O. Box 85090, 3508 AB
Utrecht, The Netherlands
123
Pediatr Cardiol (2012) 33:576–585
DOI 10.1007/s00246-012-0176-0
in both healthy and diseased individuals, including patients
with congenital heart disease [8, 9, 14, 15].
Data regarding exercise capacity in CCAVB stems from
decades-old publications reporting small case series of
unpaced patients [31, 32]. Although the current policy is to
pace patients, it is unknown whether exercise capacity
benefits from this approach.
Therefore, the aim of this cross-sectional study was to
investigate the cardiopulmonary exercise capacity of a
group of contemporary children with CCAVB with and
without pacemaker.
Methods
Study Population
The databases of the two participating departments of
pediatric cardiology (Utrecht and Nijmegen) were screened
to identify all patients[5 years old with isolated CCAVB,
which was classified as congenital if (1) CAVB was
diagnosed in utero, at birth, or within the neonatal period (0
to 27 days after birth) as proposed by Brucato et al. [6] or
(2) CAVB was diagnosed in early childhood without signs
and findings of a specific etiology (as described by Yater
et al. [46]). The diagnosis ‘‘isolated CCAVB’’ required the
absence of major structural heart defects. Eighteen patients
were identified, and 16 of them consented to participate in
the study. The medical records of those participating
patients were reviewed. Data collected included patient age
at diagnosis, maternal antibody status, patient age at first
pacemaker implantation, all pacemaker-related interven-
tions, and patient status at follow-up.
Fitness Questionnaire
To obtain information on self-perceived fitness and health,
physical activity in daily life, including sports, participa-
tion at school, and leisure, a questionnaire [4, 11] from the
Department of Integrative Physiology, St. Radboud Uni-
versity Nijmegen Medical Centre, Nijmegen, The Nether-
lands, was used. The results were compared with those
from healthy control subjects [11].
Anthropometry
Before the cardiopulmonary exercise test (CPET), anthro-
pometric measurements were completed in all patients,
including body mass (BM [kg]) and body height (m) using an
electronic scale (Seca, Hamburg, Germany) and a stadiom-
eter (Ulmer Stadiometer, Ulm, Germany), respectively.
Body mass index (BMI [kg m-2]) was calculated as BM in
kg divided by the square of the body height in meters. SD
scores were calculated for BM for age, body height for age
and BMI for age using reference values from the 1997 Dutch
Growth Study [12, 13]. To estimate body surface area (BSA
[m2]), the equation of Haycock et al. was used [19], which
has been validated in infants, children, and adults.
Echocardiography
Before CPET all patients underwent transthoracic echo-
cardiography, which was performed by the same pediatric
cardiologist (A. C. B.) with the patient at rest in supine
position using a Vivid 7 machine (GE Vingmed Ultrasound
AS, Horten, Norway). Images were obtained using a 3.5- or
5.0-MHz transducer in the suprasternal, parasternal, and
apical views. Cine-loops, including three cardiac cycles,
were stored digitally and analyzed off-line using EchoPac
version 7.0.0 software (GE Healthcare, Horten, Norway).
After a brief assessment of the cardiac anatomy, the fol-
lowing measurements were performed: M-mode; pulsed-
wave (PW) Doppler of the aortic, pulmonic, mitral, and
tricuspid valves and descending aorta; PW tissue Doppler
imaging (TDI) of the interventricular septum and left free
wall; and color-coded TDI of the left ventricle.
Assessment of Left-Ventricular Size and Function
Parasternal M-mode images were used to measure left-
ventricular (LV) end-diastolic (LVEDD) and end-systolic
diameters (LVESD). The LVEDD was compared with the
normal values of body weight-matched children [26] and
expressed as percentage of normal. LV dilatation was
defined as LVEDD C120% of normal.
Color-coded TDI of the left ventricle in the apical four-
chamber view was used to measure the peak systolic and
diastolic tissue velocity of the septal and lateral mitral
valve (MV) annulus. The velocities were compared with
values obtained in a group of healthy young individuals
[17]. Abnormal LV function was defined as measured
systolic and/ or diastolic velocities \1 SD of the mean
velocities of healthy young individuals [17].
Assessment of Dyssynchrony
Two types of dyssynchrony were assessed: interventricular
dyssynchrony and intraventricular dyssynchrony of the left
ventricle. Interventricular dyssynchrony was examined by
calculating the interventricular mechanical delay (IVMD)
using PW Doppler measurements in the left-ventricular
(LVOT) and right-ventricular outflow tracts (RVOT)
according to the following formula: (time from the onset of
QRS to the onset of PW curve in the LVOT)—(time from the
onset of QRS to the onset of PW curve in the RVOT).
Interventricular dyssynchrony was defined as being present
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if IVMD [40 ms. Intraventricular dyssynchrony of the left
ventricle was assessed by analyzing color-coded TDI of the
left ventricle in the apical four-chamber view according
to the recommendations of the American Society of Echo-
cardiography Dyssynchrony Writing Group [18]. Intraven-
tricular dyssynchrony was defined as being present if the
septal-to-lateral wall delay of the left ventricle was[65 ms.
CPET
Subjects performed a CPET using an electronically braked
cycle ergometer (Ergoline 9000; Ergoline GmbH, Bitz,
Germany) as recently described [5]. In short, patients per-
formed a CPET according to the Godfrey protocol [16]. The
end of the CPET was marked by symptom limitation. A
12-lead electrocardiogram (ECG) and pulse oximetry (Nell-
cor 200E; Nellcor, Breda, The Netherlands) were recorded
continuously throughout the entire test. Blood pressure was
measured every 2 min (SunTech Tango?; SunTech Medical,
Morrisville, NC, USA) [36]. The CPET featured a breath-by-
breath gas-exchange analysis using a calibrated expiratory
gas analysis system (Oxycon Pro; Cardinal, Houten, The
Netherlands). Peak values were defined as the highest mean
value of any 30 s time interval during exercise. Predicted
values were obtained from established values from age- and
sex-matched Dutch controls [38].
Ventilatory Threshold (VT)
The VT was determined using the criteria of an increase in
both the ventilatory equivalent of oxygen (VE/VO2) and
end-tidal pressure of oxygen (PETO2) with no increase in
the ventilatory equivalent of carbon dioxide (VE/VCO2) [7,
44]. PETO2 and PETCO2 were taken into account to dif-
ferentiate lactate buffering from hyperventilation. This
method has been validated in pediatric patients [30]. VT
was expressed as a percentage of predicted VO2peak [35].
Predicted values were obtained from established values
from age- and sex-matched Dutch controls [38].
VE/VCO2-Slope and Oxygen Uptake Efficiency Slope
(OUES)
The VE/VCO2-slope was calculated by linear least-squares
regression of the relation between VE and VCO2, respec-
tively, during the entire CPET [38]. The OUES was cal-
culated by a linear least-squares regression of the VO2 on
the common logarithm of the VE, by using the following
equation: VO2 = a logVE ? b [1]. In this equation, the
constant ‘‘a’’ stands for the regression coefficient (called
the OUES), and ‘‘b’’ represents the intercept. Predicted VE/
VCO2-slope and OUES values were obtained from estab-
lished values of age- and sex- matched Dutch controls [38].
Analysis of CPET ECG
During CPET, an electrocardiogram (ECG) was recorded
at a speed of 25 mm/s, a gain of 10 mm/mV, and muscle
filter ?50 Hz. Each minute, a 12-lead trace of several
consecutive heartbeats was printed on paper. The traces
were analyzed by the same pediatric cardiologist
(A. C. B.), who measured the following parameters:
rhythm, QRS morphology, QRS duration, and corrected
QT interval (QTc) (in normal QRS duration) or corrected
JT interval (JTc) (if QRS duration [?2SD). In addition,
the presence of arrhythmic events, including pacemaker
upper rate behavior (2:1 block or pseudo-Wenckebach),
was assessed during exercise.
Statistical Analysis
Continuous variables are presented as mean ± SD with
minimum and maximum. Nominal data are summarized as
frequencies and percentages. Differences between patients
and reference values were tested using one-sample Student
t test. Differences between the paced and unpaced group
were analyzed using independent-samples Student t test,
and p \ 0.05 was considered statistically significant. Sta-
tistical analysis was performed with IBM SPSS Statistics
18 for Mac (IBM SPSS, Chicago, IL, USA).
Results
Patient Characteristics
The characteristics of the 16 studied patients are listed in
Table 1. Patients were diagnosed with CCAVB at a mean
age of 0.2 ± 0.6 years. Maternal antibodies were detected
at diagnosis in 12 patients (75%). Thirteen patients (81%)
had a pacemaker implanted with a median number of three
implanted pacemakers. Their first pacemaker was implan-
ted at a mean age of 2.2 ± 4.1 years. Five patients (31%)
had minor associated congenital heart defects, such as
patent arterial duct (PDA = 2 patients [13%]), PDA and
atrial septal defect (PDA ? ASD = 1 patient [6%]), ven-
tricular septal defect (VSD = 1 patient [6%]), or ASD and
VSD (one patient [6%]). Two patients (13%) were on
cardiac medication: one patient used an angiotensin-con-
verting enzyme (ACE) inhibitor, and one patient used a
combination of an ACE-inhibitor and a beta-blocker.
Self-Rated Fitness, Health, and Physical Activity
The results of the questionnaire, as listed in Table 2,
identified no significant difference in the self-rated fitness
and health of paced and unpaced patients. The majority of
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CCAVB patients were always able to perform physical
activities without or with minor difficulties. Most of the
CCAVB patients judged their physical condition to be
equal to the average of their peers.
Analysis of LV Size, Function, and Dyssynchrony
The echocardiographic results are listed in Table 3.
LVEDD of the studied patients was 110 ± 10% of normal.
Table 1 Patient characteristics
Variable CCAVB group (n = 16) Paced group (n = 13) Unpaced group (n = 3)
Male (%) 7 (44)
Female (%) 9 (56)
Age at diagnosis (year) 0.2 ± 0.6a
PM (%)
No PM 3 (19)
PM 13 (81)
1st 3 (23)
2nd 4 (31)
3rd 1 (8)
4th 3 (23)
5th 2 (15)
Type of pacemaker (%)
VVIR 3 (23)
DDD 5 (38)
DDDR 3 (23)
CRT 2 (15)
Programmed upper rate (bpm) 182 ± 11a
Age at first PM implantation (year) 2.2 ± 4.1a
Maternal antibodies (%)
Negative 3 (20)
Positive 12 (75)
Minor associated CHD (%)
No 11 (69)
Yes 5 (31)
ASD/SD 1 (6)
VSD 1 (6)
PDA 2 (13)
PDA/ASD 1 (6)
Medication (%)
No 14 (88)
Yes 2 (13)
ACE-I 1 (6)
ACE-I ? BB 1 (6)
Age at CPET (y) 11.5 ± 4.1a 12.3 ± 3.9a 7.8 ± 2.8a
BM (kg) 40.2 ± 16.3a 43.9 ± 15.6a 23.9 ± 6.2a
BM for age (SD) -0.3 ± 0.9a -0.1 ± 0.9a -1.0 ± 0.4a
Body height (m) 1.47 ± 0.21a 1.52 ± 0.19a 1.24 ± 0.12a
Body height for age (SD) -0.4 ± 0.9a -0.2 ± 0.9a -1.0 ± 0.7a
BMI (kg/m2) 17.8 ± 3.0a 18.4 ± 3.0a 15.3 ± 0.9a
BMI for age (SD) -0.1 ± 1.0a 0.0 ± 1.1a -0.5 ± 0.1a
BSA (m2) 1.26 ± 0.34a 1.35 ± 0.32a 0.90 ± 0.16a
ACE-I angiotensin-converting enzyme inhibitor, CHD congenital heart disease, BB beta blocker, BM body mass, BMI body mass index, BSA
body surface area, PM pacemaker
a Data expressed as mean ± SD
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Three patients (19% [two paced and one unpaced]) had LV
dilatation. Two patients (13% [both paced]) showed systolic
and diastolic LV dysfunction. MV E velocity (0.99 ± 0.15
vs. 1.39 ± 0.08 m/s, p = 0.001), aortic valve (AoV)
velocity (1.17 ± 0.13 vs. 1.60 ± 0.03 m/s, p \ 0.0005),
and color-coded TDI lateral MV E’ velocity (-7.8 ± 1.2 vs.
-10.7 ± 0.7 cm/s, p = 0.002) were significantly higher in
unpaced patients. Eight patients (50% [all paced]) showed
interventricular dyssynchrony and one patient (6% [paced])
showed intraventricular dyssynchrony.
CPET ECG
Table 3 lists the ECG results. QRS duration during the rest
phase of CPET (145 ± 13 vs. 97 ± 6 ms, p \ 0.0005) was
significantly shorter in unpaced patients. Eleven of the
(RV) paced patients showed an LBBB-like QRS mor-
phology. Two of the (cardiac resynchronization therapy
[CRT]) paced patients had an indifferent QRS morphology.
The JTc in paced patients was 311 ± 24 ms (normal
value \ 350 ms). The QTc in unpaced patients was 420 ±
18 ms (normal value \ 440 ms). Despite of an average
programmed pacemaker upper rate of 182 ± 11 bpm, four
patients (25% [three DDDR (dual [atrial/ventricular]
paced, dual [atrial/ventricular] sensed, dual [inhibited/
triggered], rate responsive) paced and one CRT paced])
showed upper rate behavior of their pacemaker (one
pseudo-Wenckebach and three 2:1 block). No patient dis-
played premature ventricular beats.
CPET
Table 4 lists the CPET data. Peak HR (135 ± 37 bpm),
VO2peak (1.31 ± 0.50 l min
-1 [79 ± 24% of predicted]),
VO2peak kg
-1 (34.4 ± 9.5 ml kg-1 min-1 [79 ± 24% of
predicted]), peak minute ventilation (50.2 ± 22.9 l min-1
[76 ± 26% of predicted]), and VT (52 ± 17% of VO2peak
[78 ± 21% of predicted]) were all significantly lower than
those of healthy peers.
Peak work load corrected for body mass (2.8 ± 0.6
W kg-1 [91 ± 24% of predicted]), peak oxygen pulse
(10.4 ± 5.1 ml beat-1 [111 ± 56% of predicted]), peak
systolic blood pressure (131 ± 24 mmHg [99 ± 12% of
predicted]), VE/VCO2-slope (33.3 ± 6.6 [108 ± 17% of
predicted]), OUES (1424 ± 510 [92 ± 39% of predicted]),
Table 2 Physical fitness questionnaire
Variable CCAVB group (n = 16) Paced group (n = 13) Unpaced group (n = 3)
Self-rated health (scale 1–10) 8.3 ± 1.1a 8.2 ± 1.1a 9.0 ± 0.0a
Self-rated fitness (scale 1–10) 7.5 ± 1.6a 7.3 ± 1.6a 8.3 ± 1.5a
Participation in sports possible? (%)
Yes, always, without problems 5 (31) 3 (23) 2 (67)
Yes, always, with some problems 7 (44) 6 (46) 1 (33)
Yes, but not always motivated 3 (19) 3 (23)
No 1 (6) 1 (8)
All activities possible in physical education class? (%)
Yes 9 (56) 6 (46) 3 (100)
No 6 (38) 6 (46)
Self-rated condition compared with class mates (%)
Equal to mean of class 14 (88) 11 (85) 3 (100)
Less than mean of class 1 (6) 1 (8)
Would your call yourself a sportsmen? (%)
Yes, I’m a real sportsmen 1 (6) 1 (8) 1 (33)
Yes, I do a lot of sports 3 (19) 2 (15) 2 (67)
A bit 9 (56) 7 (540
No, not really 1 (6) 1 (8)
No, absolutely not 2 (13) 2 (15)
Way to school (%)
Walking 4 (25) 3 (23) 1 (33)
Bicycle 10 (63) 8 (62) 2 (67)
Car 2 (13) 2 (15)
a Data expressed as mean ± SD
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percentage of predicted FEV1 (92 ± 11%), percentage of
predicted forced expiratory vital capacity (FVC)
(87 ± 15%), and peak SpO2% (96 ± 2%) differed nonsig-
nificantly from healthy peers.
Paced CCAVB patients showed a significantly higher
HR at rest (77 ± 10 vs. 53 ± 2 bpm), lower VE/VCO2-
slope (31.8 ± 6.3 vs. 40.0 ± 1.8) and higher OUES
(1513 ± 528 vs. 1034 ± 57) compared with unpaced
patients. There were no significant differences in all other
CPET variables between paced and unpaced patients.
There were no significant differences in VO2peak kg
-1
between paced and unpaced patients (Fig. 1) and between
the various pacemaker types (Fig. 2). Peak HR of the paced
patients differed between the various pacemaker types.
DDD (dual [atrial/ventricular] paced, dual [atrial ventric-
ular] sensed, dual [inhibited/triggered])-paced patients had
the highest peak HR (171 ± 8 bpm), followed by CRT
(161 ± 8 bpm), VVIR (ventricular paced, ventricular
sensed, inhibited, rate responsive) (114 ± 25 bpm), and
DDDR-paced (98 ± 6 bpm) patients.
Discussion
The aim of this cross-sectional study was to investigate the
cardiopulmonary exercise capacity of contemporary chil-
dren with CCAVB with and without pacemaker. Our study
showed that VO2peak kg
-1 is significantly decreased in
children with CCAVB. The VO2peak kg
-1 values (34.4 ±
9.5 ml kg-1 min-1) are comparable with those observed
approximately 30 years ago in unpaced children with
CCAVB [29, 40, 43]. These studies reported an average
VO2peak kg
-1 of 36 ± 2, 37, and 31 ml kg-1 min-1,
respectively.
Furthermore, the VO2 at VT was significantly decreased
compared with healthy peers. The observed VO2 at VT
(22.9 ± 6.2 ml kg-1 min-1) was comparable with the VT
observed in unpaced children with CCAVB as reported
[20 years ago by Reybrouck et al. (22.8 ± 5.5 ml
kg-1 min-1) [32].
It is of interest to note that the peak workload corrected for
body mass was not significantly decreased in children with
Table 3 Echocardiographic and ECG data
Variable CCAVB group (n = 16) Comparison paced vs. unpaced
Paced group (n = 13) Unpaced group (n = 13)
LVEDD % norm 110 ± 10a 108 ± 10a 117 ± 11a
LV dilatation (LVEDD C 120 %norm) (%) 3 (19) 2 1
MV E velocity (m/s) 1.07 ± 0.21a 0.99 ± 0.15a 1.39 ± 0.08*,a
AoV velocity (m/s) 1.25 ± 0.21a 1.17 ± 0.13a 1.60 ± 0.03*,a
Color-coded TDI septal MV S (cm/s) 4.6 ± 0.8a 4.5 ± 0.9a 5.2 ± 0.1a
Color-coded TDI septal MV E0 (cm/s) -8.4 ± 1.6a -7.8 ± 1.2a -10.7 ± 0.7*,a
Color-coded TDI lateral MV S (cm/s) 5.9 ± 1.8a 5.6 ± 1.9a 7.0 ± 0.3a
Color-coded TDI lateral MV E0 (cm/s) -12.2 ± 3.2a -11.9 ± 3.4a -13.7 ± 0.8a
LV systolic dysfunction (%) 2 (13) 2 0
LV diastolic dysfunction (%) 2 (13) 2 0
IVMD (ms) 31 ± 38a 42 ± 34a 16 ± 2a
Interventricular dyssynchrony (%) 8 (50) 8 0
Color TVI septal-lateral delay (ms) 18 ± 23a 18 ± 26a 20 ± 10a
Intraventricular dyssynchrony (%) 1 (6) 1 0
Rest QRS duration (ms) 136 ± 23a 145 ± 13a 97 ± 6*,a
QRS morphology (%)
LBBB-like 11 (69) 11 3
IRBBB 3 (19)
Indifferent 2 (13) 2
Rest QTc (unpaced subjects) (ms) 420 ± 18a NA 420 ± 18a
Rest JTc (paced subjects) (ms) 311 ± 24a 311 ± 24a NA
PVBs (%) 0 (0) 0 0
Upper rate behavior (paced subjects) (%) 4 (25) 4 NA
IRBBB incomplete right bundle branch block, LBBB left bundle branch block
* p \ 0.05
a Data presented as mean ± SD
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CCAVB. This implies that children with CCAVB are gener-
ating more energy from anaerobic sources during exercise,
compared with healthy peers, as a compensatory mechanism
for their decreased cardiac output. Furthermore, this explains
why children with CCAVB do not frequently report exercise
intolerance [2]. Based on these figures, the question arises
whether pacemaker therapy globally improves exercise
capacity in children with CCAVB. Unexpectedly, our current
results suggest that the VO2peak and VT values of our paced
patients do not differ from those obtained in unpaced patients
from 20 to 30 years ago. Moreover, VO2peak values between
the paced and unpaced patients of our study population were
not significantly different.
Our hypothesis is that by employing the current indi-
cations for pacing in CCAVB, as reviewed by Villain [41],
only the ‘‘best’’ patients in terms of exercise capacity stay
unpaced. Apparently, the exercise capacity of these ‘‘best’’
unpaced patients can compete with the paced patients.
Thus, perhaps there are factors that prevent normalization
of exercise capacity after insertion of a pacemaker.
VO2peak is regarded as the single best parameter to describe
exercise capacity [34]. According to the Fick equation,
VO2peak is the product of three parameters: peak heart rate
(HRpeak), peak stroke volume (SVpeak), and peak arterial-
venous oxygen difference (CaO2 - CvO2); (VO2peak =
HRpeak 9 SVpeak 9 (CaO2 - CvO2)). Dynamic changes in
one of these parameters related to exercise, therefore, might
influence the oxygen transport during exercise.
Peak Heart Rate
Unpaced children with CCAVB mostly have an AV junc-
tional escape rhythm with a lower frequency than healthy
individuals at rest (average 46 [32] to 59 [37] bpm [in this
study 53 bpm]). In these patients, this frequency approxi-
mately doubles (range 1.6 [37] to 2.3 [40]) during (peak)
Table 4 CPET data
Variable Comparison CCAVB vs. healthy peers [38]
(p \ 0.05)*
Comparison paced vs. unpaced
CCAVB group (n = 16) Paced group (n = 13) Unpaced group (n = 3)
Rest HR (bpm) 73 ± 13a 77 ± 10a 53 ± 2*,a
Peak HR (bpm) (% predicted) 135 ± 37a (70 ± 19)*,a 139 ± 35a (72 ± 18)a 117 ± 48a (60 ± 25)a
VVIR 114 ± 25a
DDD 171 ± 8a
DDDR 98 ± 6a
CRT 161 ± 8a
Rest VO2 (l min
-1) 0.28 ± 0.07a 0.29 ± 0.08a 0.23 ± 0.04a
Peak RER 1.13 ± 0.11a 1.15 ± 0.12a 1.06 ± 0.01a
Peak workload/BM (W kg-1) (%
predicted)
2.8 ± 0.6a (91 ± 24)a 2.8 ± 0.6a (87 ± 23)a 3.3 ± 0.2a (112 ± 11)a
Peak VO2 (l min
-1) (% predicted) 1.31 ± 0.50a (79 ± 24)*,a 0.95 ± 0.12a (68 ± 23)a 1.39 ± 0.51a (112 ± 39)a
Peak VO2/BM (in ml kg
-1 min-1) (%
predicted)
34.4 ± 9.5a (79 ± 24)*,a 33.0 ± 9.5a (75 ± 24)a 40.5 ± 8.3a (93 ± 22)a
Peak VE (l) (% predicted) 50.2 ± 22.9a (76 ± 26)*,a 52.4 ± 24.8a (72 ± 27)a 40.7 ± 8.1a (92 ± 19)a
VT% peak VO2 (% predicted) 52 ± 17
a (78 ± 21)*,a 51 ± 18a (79 ± 22)a 53 ± 14a (73 ± 15)a
VO2/BM at VAT (ml kg
-1 min-1) 22.9 ± 6.2a 22.0 ± 6.0a 26.9 ± 6.6a
O2 pulse (ml beat
-1) (% predicted) 10.4 ± 5.1a (111 ± 56)a 10.8 ± 5.6a (98 ± 31)a 8.6 ± 1.7a (170 ± 106)a
Peak systolic BP (mmHg) (%
predicted)
131 ± 24a (99 ± 12)a 130 ± 26a (84 ± 11)a 137 ± 15a (98 ± 6)a
VE/VCO2 slope (% predicted) 33.3 ± 6.6
a (108 ± 17)a 31.8 ± 6.3a (105 ± 18)a 40.0 ± 1.8*,a (121 ± 2)a
OUES (% predicted) 1424 ± 510a (92 ± 39)a 1513 ± 528a (81 ± 23)a 1034 ± 57*,a (141 ± 60)*,a
FEV1% predicted 92 ± 11a 92 ± 12a 89 ± 5a
FVC% predicted 87 ± 15a 87 ± 16a 87 ± 13a
Peak oxygen saturation (%) 96 ± 2a 96 ± 3a 97 ± 1a
RER respiratory exchange ratio, O2 pulse peak VO2/peak HR, BP blood pressure
* (p \ 0.05)
a Data presented as mean ± SD
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exercise to an average frequency of 94 [37] to 117 [in this
study]). A pacemaker will restore the frequencies at rest as
well as during exercise. The extent of frequency restoration
depends on the pacemaker mode (e.g., single chamber
[VVI] vs. dual chamber (DDD), use of rate response) and
the pacemaker programming. Our study showed that the
average peak HR of paced CCAVB patients is still lower
than in healthy individuals. There are two reasons for that
finding. First, approximately half of the paced patients had
a rate-responsive pacemaker (i.e., VVIR or DDDR). They
showed a lower average peak HR compared with DDD- or
CRT-paced patients. This means that the sensor sensitivity
was not appropriate for the type of exercise (cycling). All
rate-responsive pacemakers in our study used an acceler-
ometer as activity sensor. Theoretically, an accelerometer
should be sensitive to bicycling because it detects hori-
zontal movement [42]. However, it is designed for use in
adult patients with the pacemaker implanted in the pectoral
region [3]. The majority of patients with a rate-responsive
pacemaker in our study had their device implanted in the
abdominal region, which blunted the response of their
accelerometer during bicycling. Our results underscore the
necessity to use the treadmill instead of the bicycle for the
exercise testing of pediatric patients with a rate-responsive
pacemaker.
Second, despite an average programmed pacemaker
upper rate (maximum tracking rate [MTR]) 182 ± 11 bpm
minute, 25% of the paced patients showed upper rate
behavior of the pacemaker during the CPET, which limited
their exercise capacity significantly. These results show
that pediatric CCAVB patients would benefit from
MTRs [ 180 bpm. Unfortunately, not all pacemaker
models and manufacturers support MTRs in that range.
Finally, another factor that might influence peak HR is the
occurrence of premature ventricular beats (PVBs). Earlier
studies showed a high incidence (27% [22] to 70% [45]) of
PVBs in unpaced CCAVB patients. However, no patient in
our study displayed PVBs.
Peak Stroke Volume
The stroke volume is influenced by cardiac preload, myo-
cardial contractility, and cardiac afterload. There is a dif-
ference in these parameters between unpaced and paced
CCAVB patients. In unpaced patients, according to
Scarpelli and Rudolph [33], the long diastolic filling in
bradycardia causes an increased end-diastolic volume with
stretching of the myocardial fibres, augmenting myocardial
contractility. Indeed, Kertesz et al. [23] demonstrated that
moderate LV dilatation is common in these patients and is
associated with a normal LV geometry, normal wall stress,
and enhanced systolic function during the first two decades
of life. The data of this study support the findings of
Scarpelli and Rudolph and Kertesz et al. The LV end
diastolic diameter was greater (although not significantly)
in unpaced patients, and one patient had LV dilatation. The
MV Doppler inflow velocity was significantly greater in
unpaced patients, suggesting an unfavorable relaxation of
the stretched left ventricle. All unpaced CCAVB patients
had normal LV function.
Paced CCAVB patients had a lower LVEDD and MV
Doppler inflow velocity, suggesting less stretching and
better relaxation of the left ventricle. However, two of 13
paced patients (15%) showed LV dysfunction (with LV
Fig. 1 Percentage of predicted peak oxygen uptake/body mass
(VO2peak kg
-1) of unpaced and paced CCAVB patients. Box-and-
whisker diagram: horizontal line in the box depicts median value; the
box includes 50% of the values; the upper whisker represents the top
25% of the values; and the lower whisker represents the bottom 25%
of the values
Fig. 2 Percentage of predicted peak oxygen uptake/body mass
(VO2peak kg
-1) of unpaced and paced CCAVB patients. The paced
patients are subdivided according to their pacemaker type. Box-and-
whisker diagram: horizontal line in the box depicts median value; the
box includes 50% of the values; the upper whisker represents the top
25% of the values; and the lower whisker represents the bottom 25%
of the values
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dilatation in one patient). This might be a result of chronic
pacing. Earlier studies have shown that chronic (right)
ventricular pacing causes an abnormal electrical activation
that may lead to mechanical dyssynchrony (seen in 62% of
the paced patients in this study), LV remodeling, LV
dilatation, LV dysfunction, and low exercise capacity [28,
39].
The majority of our patients (87%) had normal LV
function at rest. Yet, stroke volume can increase as well as
decrease during exercise in the presence of normal LV
function at rest [20, 21, 37]. Therefore, future studies
should include exercise echocardiography with (noninva-
sive) measurement of stroke volume.
Arterial–Venous Oxygen Difference
Although our study does not include (invasive) measure-
ment of the oxygen content of the arterial and venous
blood, earlier studies showed a normal (13.8 [43] to 14.5
[29] ml/100 ml) or increased [21] average arterial–venous
oxygen difference during (peak) exercise in patients with
CCAVB. It is therefore unclear whether children with
CCAVB have an increased arterial–venous oxygen differ-
ence during exercise as a compensatory mechanism for
their decreased cardiac output.
Study Limitations
A limitation of this study was that our data were obtained
cross-sectionally from a rather small group of patients
in two University Children’s Hospitals. In contrast, all
patients were tested by the same experienced staff using the
same equipment to avoid interobserver or technical vari-
ability. Future additional studies should be performed in a
larger patient population and should preferably include
more unpaced CCAVB patients (although lack of avail-
ability is a limitation in itself). In addition, longitudinal
exercise data are desirable for investigating the effects of
pacemaker therapy on exercise capacity in this population.
In conclusion, children with CCAVB show a decreased
peak oxygen uptake and VT, whereas they show normal
peak work rates. This indicates that they generate more
energy from anaerobic energy sources during exercise.
Paced children with CCAVB do not perform better than
unpaced children. Possible explanations for that finding
might be: (1) a selection bias imposed by the current
pacemaker criteria (only the clinically ‘‘best’’ CCAVB
patients stay unpaced), (2) chronic RV pacing–induced LV
dysfunction in some CCAVB patients, and (3) suboptimal
pacemaker programming.
Future exercise studies, including a greater number of
patients and longitudinal follow-up, are warranted to
investigate the influence of myocardial properties (LV
dysfunction), pacing mode, and optimal pacemaker pro-
gramming on exercise capacity.
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